Free Trial

Firefly Neuroscience Q2 2024 Earnings Report

Firefly Neuroscience logo
$4.47 -0.10 (-2.19%)
As of 02/28/2025 04:00 PM Eastern

Firefly Neuroscience EPS Results

Actual EPS
-$0.58
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Firefly Neuroscience Revenue Results

Actual Revenue
$1.90 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Firefly Neuroscience Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Firefly Neuroscience Earnings Headlines

Firefly Neuroscience announces exercise of warrants for $8.8M
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most important money managers of our time" — reveals the company's name and ticker symbol at no cost. But he cautions: once mainstream investors recognize what's happening, the opportunity for maximum gains could evaporate overnight.
See More Firefly Neuroscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Firefly Neuroscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Firefly Neuroscience and other key companies, straight to your email.

About Firefly Neuroscience

Firefly Neuroscience (NASDAQ:AIFF), a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

View Firefly Neuroscience Profile

More Earnings Resources from MarketBeat